Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Milpied

Showing results (151-160 of 240) with videos related to

Pageof 24
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 5, 2001
Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplantsE Ninin, N Milpied, P Moreau, et al.
British Journal of Haematology|December 1, 1996
A pilot study of 220 mg/m2 melphalan followed by autologous stem cell transplantation in patients with advanced haematological malignancies: pharmacokinetics and toxicityP Moreau, M F Kergueris, N Milpied, et al.
Annales De Genetique|January 1, 1997
Chromosome aberrations after radiotherapy in patients treated for non Hodgkin's lymphomaM A Mahé, M J André, E Moyon, et al.
Lancet (London, England)|March 26, 1994
Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study GroupH G Prentice, E Gluckman, R L Powles, et al.
British Journal of Haematology|April 12, 2000
Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leukaemias Working Party (CLWP)M Michallet, A Thiébaut, P Dreger, et al.
Leukemia|April 16, 2014
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trialD Rossille, M Gressier, D Damotte, et al.
Cancer Causes & Control : CCC|November 28, 2007
UV radiation exposure, skin type and lymphoid malignancies: results of a French case-control studyL Grandin, L Orsi, X Troussard, et al.
Blood|March 15, 1996
HLA-target antigens and T-cell receptor diversity of activated T cells invading the skin during acute graft-versus-host diseaseJ Gaschet, M A Treviño, M Cherel, et al.
Bone Marrow Transplantation|July 23, 1998
Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot studyP Moreau, N Milpied, L Voillat, et al.
Bone Marrow Transplantation|November 1, 1994
Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignanciesD P Wu, N Milpied, P Moreau, et al.
Pageof 24

Showing results (151-160 of 240) with videos related to

Sort By:
Pageof 24
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 5, 2001
Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplantsE Ninin, N Milpied, P Moreau, et al.
British Journal of Haematology|December 1, 1996
A pilot study of 220 mg/m2 melphalan followed by autologous stem cell transplantation in patients with advanced haematological malignancies: pharmacokinetics and toxicityP Moreau, M F Kergueris, N Milpied, et al.
Annales De Genetique|January 1, 1997
Chromosome aberrations after radiotherapy in patients treated for non Hodgkin's lymphomaM A Mahé, M J André, E Moyon, et al.
Lancet (London, England)|March 26, 1994
Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study GroupH G Prentice, E Gluckman, R L Powles, et al.
British Journal of Haematology|April 12, 2000
Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leukaemias Working Party (CLWP)M Michallet, A Thiébaut, P Dreger, et al.
Leukemia|April 16, 2014
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trialD Rossille, M Gressier, D Damotte, et al.
Cancer Causes & Control : CCC|November 28, 2007
UV radiation exposure, skin type and lymphoid malignancies: results of a French case-control studyL Grandin, L Orsi, X Troussard, et al.
Blood|March 15, 1996
HLA-target antigens and T-cell receptor diversity of activated T cells invading the skin during acute graft-versus-host diseaseJ Gaschet, M A Treviño, M Cherel, et al.
Bone Marrow Transplantation|July 23, 1998
Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot studyP Moreau, N Milpied, L Voillat, et al.
Bone Marrow Transplantation|November 1, 1994
Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignanciesD P Wu, N Milpied, P Moreau, et al.
Pageof 24